Market access in Europe and India demands precision — not guesswork. GMDA’s Strategic Intelligence division provides MedTech companies with the actionable data and market insights needed to make informed decisions about pricing, reimbursement, and market entry sequencing.
Our proprietary market analysis framework covers all 27 EU member states and India’s top healthcare markets, including detailed assessments of: hospital procurement cycles, reimbursement pathways, competitive landscape mapping, pricing benchmarks across single-payer and multi-payer systems, and key opinion leader identification.
For Indian market entry, we provide exclusive intelligence on distribution channel dynamics, government tender processes, private hospital network purchasing patterns, and regulatory pathway optimization. This intelligence is not available through conventional consulting firms — it comes from GMDA’s direct operational presence and relationships on the ground.
Regulatory compliance is not merely a hurdle — it is the foundation of your commercial strategy. GMDA’s Regulatory Acceleration team transforms the complex EU MDR framework and India’s CDSCO requirements into a strategic advantage that compresses your time-to-market by up to 40%.
Our EU regulatory capabilities include: full EU MDR compliance management, Notified Body liaison and submission management, technical file preparation and review, clinical evaluation report development, post-market surveillance system design, and CE marking strategy optimization.
For Indian market access, GMDA manages the complete CDSCO registration process, including: import license applications, clinical trial waivers where applicable, state-level registration requirements, and ongoing compliance monitoring. Our integrated approach ensures that regulatory work in one market accelerates — rather than duplicates — efforts in the other.
GMDA’s operational headquarters in Sofia, Bulgaria serves as the perfect launch pad for dual-continent market entry. Bulgaria’s strategic position within the EU Single Market, combined with its 10% flat corporate tax rate — the lowest in the EU — provides our clients with a significant cost advantage while maintaining full EU regulatory compliance.
Our Sofia hub provides: EU-compliant warehousing and logistics management, import/export facilitation for both EU and Indian markets, quality management system (QMS) infrastructure, local entity setup and corporate governance support, talent acquisition for local commercial teams, and financial and tax optimization structuring.
This operational model eliminates the need for MedTech companies to establish their own costly European subsidiaries. GMDA provides a turnkey operational infrastructure that allows companies to focus on what they do best — developing innovative medical technologies — while we handle the complexities of multi-market commercial operations.
Market access without commercial execution is a wasted investment. GMDA’s Commercial Scale division is where strategy meets revenue. We don’t just open doors — we drive adoption, build sustainable revenue streams, and position our portfolio companies for long-term market leadership.
In Europe, our commercial capabilities include: direct hospital procurement engagement across 15+ countries, KOL network activation and clinical champion development, medical education and training program design, conference and trade show representation, and reimbursement dossier development and health economics support.
In India, GMDA’s exclusive control over the top 5 MedTech distribution channels provides unparalleled market reach. Our Indian commercial operations include: national distributor management and performance optimization, government tender preparation and submission, private hospital chain account management, and regional sales team deployment and training. This dual-continent commercial engine is what transforms a regulatory clearance into a scalable, profitable business.
